Characteristics of patients with coeliac disease (CD)
| Patient No | Sex/Age | Diagn | Histo† | EMA* | PET result | SUV | Onset of gluten free diet prior to PET (months) |
|---|---|---|---|---|---|---|---|
| RS, refractory sprue; SUV, standard uptake value; FDG, fluoro-deoxy-glucose; PET, positron emission tomography | |||||||
| *EMA, endomysial antibodies semiquantitatively classified from 0 to 3. | |||||||
| †Histology according to modified Marsh criteria. | |||||||
| ‡Non-compliant. | |||||||
| 1 | F/58 | CD | 0 | 0 | Diffuse intestinal FDG uptake | 3.0 | 75 |
| 2 | F/42 | CD | 0 | 0 | Negative | Negative | 35 |
| 3 | F/59 | CD‡ | 3c | 3+ | Negative negative | Negative negative | 212‡ |
| 0 | 0 | 223 | |||||
| 4 | F/74 | RS | 3a | 1 | Diffuse intestinal FDG uptake | 1st PET: 2.9 | 140 |
| 2a | 0 | 2nd PET 2.2 | 154 | ||||
| 5 | F/76 | CD‡ | 3a | 3+ | Both PET scans: diffuse intestinal FDG | 1st PET: 4.2; 2nd PET: no SUV | 170‡ |
| 0 | 0 | uptake | available | 173 | |||
| 6 | M/55 | CD | 3c | 0 | Diffuse intestinal FDG uptake | 4.6 | 4 |
| 7 | M/56 | RS | 3c | 0 | Intestinal FDG uptake | 3.5 | 60 |
| 8 | M/58 | CD | 3b-c | 1 | Negative | Negative | 4 |
| 9 | M/63 | CD‡ | 3b | 3 | Minimal diffuse intestinal FDG uptake | No SUV available | 74‡ |
| 10 | F/76 | CD | 3a | 0 | Negative | Negative | 72 |
| 11 | F/67 | CD‡ | 3b | 3+ | Minimal diffuse intestinal FDG uptake | No SUV available | 48 |
| 12 | M/82 | RS | 3a | 0 | 1st and 2nd PET: minimal diffuse | No SUV available | 12 |
| 3b | 0 | intestinal FDG uptake without dynamics | 32 | ||||